Monday, April 15, 2024 Apr 15, 2024
69° F Dallas, TX
Advertisement
News

DFW Healthcare Brief: CHRISTUS Health Adds New Mexico Hospital to its Network and Texas Health Plano’s NICU Expansion

Plus Verily appoints new General Counsel and AyuVis lands another NIH grant.
|
Image
A rendering of the Texas Health Plano NICU room expansion. Courtesy: Texas Health Plano

Gerald Champion Regional Medical Center in Alamogordo, New Mexico is now part of the Irving-based CHRISTUS Health’s network. The two organizations officially united on July 1 without a disruption in services or procedures in the hospital. Founded in 1949, Champion is a 98-bed hospital that will now be a part of the international nonprofit health system with three other care sites in New Mexico, 36 sites in Texas, and six in Louisiana. Champion employs 160 providers and 1,000 staff that see about 4,000 admissions each year.


Texas Health Presbyterian Hospital Plano is building a $3.9 million expansion of the hospital’s neonatal intensive care unit family center. The hospital is Collin County’s only Level IV neonatal intensive care unit that saw 406 admissions in 2022. The expansion is meant to support the families of infant who spend several days in the hospital and will have private hotel-style rooms to accommodate overnight stays, a welcome lounge, and coffee bar. After the expansion, Texas Health Plano will have 43 NICU beds, including two rooms dedicated for twins and triplets.


Verily has appointed the former McKesson Chief Compliance Officer Laura O’Donnell to be its General Counsel. Verily is owned by Alphabet (Google’s parent company), is focused on precision medicine, and has a regional headquarters in Coppell where its CEO offices. O’Donnell was McKesson’s first Chief Compliance Officer and transformed the company’s approach to regulatory and operational excellence and led its COVID-19 Executive Response Team. She previously served as General Counsel of GE Healthcare and CCO at Zimmer Biomet.


Fort-Worth based AyuVis is set to received a $2.1 million research grant from the National Institute of Health (NIH) National Heart, Lung, and Blood Institute to fund its Phase 1 clinical trial of its immunotherapy treatment that controls inflammation and infection while treating immune disorder diseases. This is the fourth NIH grant AyuVis has received, totaling $4.2 million. AyuVis’ first treatment is focused on the prevention of bronchopulmonary dysplasia a chronic lung disease in preterm babies without any FDA-approved therapies.

Author

Will Maddox

Will Maddox

View Profile
Will is the senior writer for D CEO magazine and the editor of D CEO Healthcare. He's written about healthcare…

Related Articles

Image
Media

Mike Mooney Has a New Podcast About ‘The World’s Largest Sex Trafficker’

His new Audible show, Hold Fast, drops today. It's about Backpage.com.
Image
News

DFWHC’s Steve Love Named Chair-Elect of Irving Chamber and Medical City Again Wins ‘Best Place to Have a Baby’

Plus Red River Hospital's New CEO and Texas Recognized by Fortune as Best Place to Work.
Image
Restaurant News

Lucia, Gemma, and Petra and the Beast Are Dallas’ James Beard Award Finalists

Misti Norris, David Uygur, and the hospitality at Gemma are being celebrated this year.
Advertisement